Picton Mahoney Asset Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Picton Mahoney Asset Management’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-106,500	Closed	-$5.59M	–	493
2020 Q3	$5.59M	Buy	+106,500	New	+$4.41M	0.31%	98
2015 Q1	–	Sell	-15,300	Closed	-$184K	–	375
2014 Q4	$184K	Buy	+15,300	New	+$175K	0.01%	202

Picton Mahoney Asset Management's MNTA Position: Q4 2020 in Review

Picton Mahoney Asset Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 106,500 shares — an estimated $5.59M sold.

Picton Mahoney Asset Management first reported a position in MNTA in Q4 2014 and held it in 2 quarters. The position peaked at $5.59M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

Picton Mahoney Asset Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
Picton Mahoney Asset Management sold 106,500 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $5.59M.
Picton Mahoney Asset Management first reported a position in Momenta Pharmaceuticals, Inc. in Q4 2014 and held it in 2 quarters.
Picton Mahoney Asset Management's Momenta Pharmaceuticals, Inc. position peaked at $5.59M in Q3 2020.
0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Picton Mahoney Asset Management's 13F filing for Q4 2020, filed 12 Feb 2021.